Sales decline 8.48% to Rs 21.16 crore
Net Loss of Bafna Pharmaceuticals reported to Rs 2.90 crore in the quarter ended June 2016 as against net loss of Rs 1.19 crore during the previous quarter ended June 2015. Sales declined 8.48% to Rs 21.16 crore in the quarter ended June 2016 as against Rs 23.12 crore during the previous quarter ended June 2015. ParticularsQuarter EndedJun. 2016Jun. 2015% Var.Sales21.1623.12 -8 OPM %3.648.69 -PBDT-1.94-0.10 -1840 PBT-2.95-1.12 -163 NP-2.90-1.19 -144Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
